AstraZeneca
AstraZeneca is a global biopharmaceutical company known for its innovative medicines, particularly in the fields of oncology, cardiovascular, renal, and respiratory diseases. Recently, the company announced a significant investment of $2.5 billion to establish a global strategic research and development center in Beijing.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| China | 1 | 7.00 | 0.07% | +0% | 1,402,112,000 | 924,266 | $14,000,000 | 9,229$ |
| Hong Kong | 1 | 8.00 | 0.14% | +0% | 7,500,700 | 10,685 | $370,000 | 527$ |
| Totals | 2 | 1,409,612,700 | 934,951 | $14,370,000 | 9,756$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
China:
AstraZeneca announced plans to invest over 100 billion yuan in China by 2030 to expand its pharmaceutical production.
7
Hong Kong:
AstraZeneca announced plans to invest over 100 billion yuan in China by 2030.
8
Costa Rica:
AstraZeneca announced multimillion-dollar investments in the United States, committing to reduce their fees in exchange for tariff exemptions.
6
China:
AstraZeneca announced an additional investment of $136 million to expand its production capacity in Qingdao.
7
Russia:
AstraZeneca insists on the legality of its existing patent and its rights to the drug.
6
China:
AstraZeneca announced a $2.5 billion investment plan to establish a global strategic R&D center in Beijing.
9
Hong Kong:
AstraZeneca announced an investment of $2.5 billion to establish a global strategic R&D center in Beijing.
7